10 drugs costing Medicare Part D the most

Medicare covered 30 percent of prescription drug costs, or $101 billion, in 2017, according to a new Kaiser Family Foundation study.

The 10 drugs costing Medicare the most:

1. Harvoni ($4.4 billion)
2. Revlimid ($2.6 billion)
3. Lantus Solostar ($2.5 billion)
4. Januvia ($2.4 billion)
5. Crestor ($2.3 billion)
6. Advair Diskus ($2.3 billion)
7. Lyrica ($2.1 billion)
8. Xarelto ($1.9 billion)
9. Eliquis ($1.9 billon)
10. Spiriva ($1.8 billion)

More articles on pharmacy:
How hospitals can better align the pharmacy to achieve its strategic goals
Google sister-company Verily partners with big pharma for clinical trials
Merck's Keytruda fails late-stage trial as standalone treatment for breast cancer

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Content

Featured Webinars

Featured Whitepapers